Article PDF
References
Nieto FJ, Young TB, Lind BK, et al: Association of sleep-disordered breathing, sleep apnea, and hypertension in a large community-based study. JAMA 2000; 283: 1829–1836.
Lavie P, Herer P, Hoffstein V : Obstructive sleep apnoea syndrome as a risk factor for hypertension: population study BMJ 2000; 320: 479–482.
Peppard PE, Young T, Palta M, Skatrud J : Prospective study of the association between sleep-disordered breathing and hypertension. N Engl J Med 2000; 342: 1378–1384.
Shahar E, Whitney CW, Redline S, et al: Sleep-disordered breathing and cardiovascular disease: cross-sectional results of the sleep heart health study. Am J Respir Crit Care Med 2001; 163: 19–25.
Marin JM, Carrizo SJ, Vicente E, Agusti AG : Long-term cardiovascular outcomes in men with obstructive sleep apnoea-hypopnoea with or without treatment with continuous positive airway pressure: an observational study. Lancet 2005; 365: 1046–1053.
Arias MA, Garcia-Rio F, Alonso-Fernandez A, Martinez I, Villamor J : Pulmonary hypertension in obstructive sleep apnoea: effects of continuous positive airway pressure: a randomized, controlled cross-over study. Eur Heart J 2006; 27: 1106–1113.
Guilleminault C, Connolly SJ, Winkle RA : Cardiac arrhythmia and conduction disturbances during sleep in 400 patients with sleep apnea syndrome. Am J Cardiol 1983; 52: 490–494.
Munoz R, Duran-Cantolla J, Martinez-Vila E, et al: Severe sleep apnea and risk of ischemic stroke in the elderly. Stroke 2006; 37: 2317–2321.
Hedner J, Ejnell H, Caidahl K : Left ventricular hypertrophy independent of hypertension in patients with obstructive sleep apnoea. J Hypertens 1990; 8: 941–946.
Noda A, Okada T, Yasuma F, Nakashima N, Yokota M : Cardiac hypertrophy in obstructive sleep apnea syndrome. Chest 1995; 107: 1538–1544.
Cloward TV, Walker JM, Farney RJ, Anderson JL : Left ventricular hypertrophy is a common echocardiographic abnormality in severe obstructive sleep apnea and reverses with nasal continuous positive airway pressure. Chest 2003; 124: 594–601.
Tkacova R, Rankin F, Fitzgerald FS, Floras JS, Bradley TD : Effects of continuous positive airway pressure on obstructive sleep apnea and left ventricular after-load in patients with heart failure. Circulation 1998; 98: 2269–2275.
Mahler F, Ross J Jr, O'Rourke RA, Covell JW : Effects of changes in preload, afterload and inotropic state on ejection and isovolumic phase measures of contractility in the conscious dog. Am J Cardiol 1975; 35: 626–634.
Ross J Jr : Afterload mismatch and preload reserve: a conceptual framework for the analysis of ventricular function. Prog Cardiovasc Dis 1976; 18: 255–264.
Pepperell JC, Ramdassingh-Dow S, Crosthwaite N, et al: Ambulatory blood pressure after therapeutic and subtherapeutic nasal continuous positive airway pressure for obstructive sleep apnoea: a randomised parallel trial. Lancet 2001; 359: 204–210.
Faccenda JF, Mackay TW, Boon NA, Douglas NJ : Randomized placebo-controlled trial of continuous positive airway pressure on blood pressure in the sleep apnea/hypopnea syndrome. Am J Respir Crit Care Med 2001; 163: 344–348.
Becker HF, Jerrentrup A, Ploch T, et al: Effect of nasal continuous positive airway pressure treatment on blood pressure in patients with obstructive sleep apnea. Circulation 2003; 107: 68–73.
Heindl S, Dodt C, Krahwinkel M, Hasenfuss G, Andreas S : Short term effect of continuous positive airway pressure on muscle sympathetic nerve activity in patients with chronic heart failure. Heart 2001; 85: 185–190.
Kaneko Y, Floras JS, Usui K, et al: Cardiovascular effects of continuous positive airway pressure in patients with heart failure and obstructive sleep apnoea. N Engl J Med 2003; 348: 1233–1241.
Cloward TV, Walker JM, Farney RJ, Anderson JL : Left ventricular hypertrophy is a common echocardiographic abnormality in severe obstructive sleep apnea and reverses with nasal continuous positive airway pressure. Chest 2003; 124: 594–601.
Møller DS, Lind P, Strunge B, Pedersen EB : Abnormal vasoactive hormones and 24-hour blood pressure in obstructive sleep apnea. Am J Hypertens 2003; 16: 274–280.
Kokturk O, Ciftci TU, Mollarecep E, Ciftci B : Elevated C-reactive protein levels and increased cardiovascular risk in patients with obstructive sleep apnea syndrome. Int Heart J 2005; 46: 801–809.
Minoguchi K, Tazaki T, Yokoe T, et al: Elevated production of tumor necrosis factor-alpha by monocytes in patients with obstructive sleep apnea syndrome. Chest 2004; 126: 1473–1479.
Ryan S, Taylor CT, McNicholas WT : Selective activation of inflammatory pathways by intermittent hypoxia in obstructive sleep apnea syndrome. Circulation 2005; 112: 2660–2667.
Schulz R, Mahmoudi S, Hattar K, et al: Enhanced release of superoxide from polymorphonuclear neutrophils in obstructive sleep apnea. Impact of continuous positive airway pressure therapy. Am J Respir Crit Care Med 2000; 162 ( 2 Pt 1): 566–570.
Mehta PK and Griendling KK : Angiotensin II cell signaling: physiological and pathological effects in the cardiovascular system. Am J Physiol Cell Physiol 2007; 292: C82–C97.
Li YL, Gao L, Zucker IH, Schultz HD : NADPH oxidase–derived superoxide anion mediates angiotensin II–enhanced carotid body chemoreceptor sensitivity in heart failure rabbits. Cardiovasc Res 2007; 75: 546–554.
Gao L, Wang W, Li YL, et al: Superoxide mediates sympathoexcitation in heart failure: roles of angiotensin II and NAD(P)H oxidase. Circ Res 2004; 95: 937–944.
Nishio M, Sakata Y, Mano T, et al: Therapeutic effects of angiotensin II type 1 receptor blocker at an advanced stage of hypertensive diastolic heart failure. J Hypertens 2007; 25: 455–461.
Nishioka T, Suzuki M, Onishi K, et al: Eplerenone attenuates myocardial fibrosis in the angiotensin II–induced hypertensive mouse: involvement of tenascin-C induced by aldosterone-mediated inflammation. J Cardiovasc Pharmacol 2007; 49: 261–268.
Stas S, Whaley-Connell A, Habibi J, et al: Mineralocorticoid receptor blockade attenuates chronic overexpression of the renin-angiotensin-aldosterone system stimulation of reduced nicotinamide adenine dinucleotide phosphate oxidase and cardiac remodeling. Endocrinology 2007; 148: 3773–3780.
Yamashita C, Hayashi T, Mori T, et al: Angiotensin II receptor blocker reduces oxidative stress and attenuates hypoxia-induced left ventricular remodeling in apolipoprotein E–knockout mice. Hypertens Res 2007; 30: 1219–1230.
Adamy C, Oliviero P, Eddahibi S, et al: Cardiac modulations of ANG II receptor expression in rats with hypoxic pulmonary hypertension. Am J Physiol Heart Circ Physiol 2002; 283: H733–H740.
Irlbeck M, Iwai T, Lerner T, Zimmer HG : Effects of angiotensin II receptor blockade on hypoxia-induced right ventricular hypertrophy in rats. J Mol Cell Cardiol 1997; 29: 2931–2939.
Kadotani H, Kadotani T, Young T, et al: Association between apolipoprotein E epsilon4 and sleep-disordered breathing in adults. JAMA 2001; 285: 2888–2890.
Gottlieb DJ, DeStefano AL, Foley DJ, et al: APOE epsilon4 is associated with obstructive sleep apnea/hypopnea: the Sleep Heart Health Study. Neurology 2004; 63: 664–668.
Okada T, Kayukawa Y, Ohta T, Katsumata K : Epidemiology and prognosis of sleep apnea syndromes. Kokyu To Junkan 1989; 37: 39–43 ( in Japanese).
Young T, Palta M, Dempsey J, Skatrud J, Weber S, Badr S : The occurrence of sleep-disordered breathing among middle-aged adults. N Engl J Med 1993; 328: 1230–1235.
Chobanian AV, Bakris GL, Black HR, et al, National Heart, Lung, and Blood Institute Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure; National High Blood Pressure Education Program Coordinating Committee : The Seventh Report of the Joint National Commitee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA 2003; 289: 2560–2572.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Miwa, Y., Sasaguri, T. Hypoxia-Induced Cardiac Remodeling in Sleep Apnea Syndrome: Involvement of the Renin-Angiotensin-Aldosterone System. Hypertens Res 30, 1147–1149 (2007). https://doi.org/10.1291/hypres.30.1147
Received:
Issue Date:
DOI: https://doi.org/10.1291/hypres.30.1147